Comprehensive overview of vitiligo including causes, symptoms, diagnosis, and treatments with clinical examples and notable cases.
Key Takeaways
- Vitiligo results from melanocyte loss causing skin depigmentation.
- Genetic and autoimmune factors play significant roles in its development.
- Diagnosis is clinical; thyroid tests may be ordered due to common associations.
- Topical corticosteroids and UV therapy are primary treatments.
- Complete depigmentation therapy can be used for extensive vitiligo to achieve uniform skin tone.
Summary
- Vitiligo is a skin condition characterized by loss of melanocytes leading to depigmentation.
- Etiology includes genetic factors (autosomal dominant), autoimmune causes, and occupational exposure to chemicals.
- Commonly affects face, hands, and fingers, with more pronounced appearance in darker skin tones.
- Diagnosis is primarily clinical, sometimes supported by thyroid function tests due to associated thyroid disorders.
- First-line treatment involves topical corticosteroids to blend depigmented patches with normal skin.
- Ultraviolet (UV) therapy is also used as a treatment option.
- Complete depigmentation of normal skin using monobenzyl ether or hydroquinone can achieve uniform skin tone.
- Michael Jackson is a famous example of vitiligo, who underwent full-body depigmentation treatment.
- Clinical vignettes illustrate occupational vitiligo and pediatric cases with family history of autoimmune diseases.
- Management excludes antifungals, chemotherapy, and sun avoidance; focuses on corticosteroids and phototherapy.











